title: Medical therapy of pituitary adenomas: effects on tumor shrinkage.
abstract: The efficacy of dopamine-agonists (DA) in patients with prolactinomas and that of somatostatin analogues (SSA) in those with GH- and TSH-secreting adenomas is well established. More recently, data are accumulating suggesting a potential therapeutic role of DA also in patients with ACTH-secreting and clinically non-functioning (NFA) pituitary adenomas. This review aims at summarizing published results of DA and SSA on tumor shrinkage in patients with different histotypes of pituitary adenomas. Results of tumor shrinkage are of clinical relevance as tumor size is the one of the most important determinant of surgical outcome. While reduction of tumor size more than 50% of baseline size in macroprolactinomas treated with DA is a frequent finding in patients with GH-secreting adenomas treated with SSA tumor shrinkage only recently is becoming frequent thanks to the availability of depot formulations. Data on tumor shrinkage in patients with TSH-secreting adenomas treated with SSA are limited because of the rarity of these tumors. Very recently, DA have been reported of some efficacy also in patients with ACTH-secreting adenomas but data are still very limited. NFA respond very scantly to both DA and SSA even if receptors targeting these drugs are present. Whether this is due to limited receptor number or alterations of post-receptor pathway is still unknown.
authors.affiliation: Department of Molecular & Clinical Endocrinology and Oncology, Federico II University of Naples, Naples, Italy. colao@unina.it
authors.forename: Annamaria
authors.initials: A
authors.lastname: Colao
authors.forename: Rosario
authors.initials: R
authors.lastname: Pivonello
authors.forename: Carolina
authors.initials: C
authors.lastname: Di Somma
authors.forename: Silvia
authors.initials: S
authors.lastname: Savastano
authors.forename: Ludovica F S
authors.initials: LF
authors.lastname: Grasso
authors.forename: Gaetano
authors.initials: G
authors.lastname: Lombardi
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D018491:Dopamine Agonists / Q000627:therapeutic use; D013006:Growth Hormone / Q000378:metabolism; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D010911:Pituitary Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D013972:Thyrotropin / Q000378:metabolism
chemical_list: D018491:Dopamine Agonists; D006728:Hormones; D013004:Somatostatin; D000324:Adrenocorticotropic Hormone; D013972:Thyrotropin; D013006:Growth Hormone
references.citation: J Clin Endocrinol Metab. 1994 Nov;79(5):1416-23
references.pmid: 7962337
references.citation: J Clin Endocrinol Metab. 2002 Jul;87(7):3013-8
references.pmid: 12107192
references.citation: J Endocrinol Invest. 2009 Mar;32(3):202-9
references.pmid: 19542735
references.citation: J Clin Endocrinol Metab. 2007 May;92(5):1592-9
references.pmid: 17311860
references.citation: Clin Cancer Res. 2007 May 1;13(9):2738-44
references.pmid: 17473207
references.citation: Nature. 1989 Dec 21-28;342(6252):923-6
references.pmid: 2531847
references.citation: J Clin Endocrinol Metab. 2008 Jul;93(7):2454-62
references.pmid: 18413427
references.citation: Expert Opin Investig Drugs. 2002 Jun;11(6):787-800
references.pmid: 12036422
references.citation: Clin Endocrinol (Oxf). 2006 Feb;64(2):209-14
references.pmid: 16430722
references.citation: Endocr Pract. 2007 Jul-Aug;13(4):396-402
references.pmid: 17669717
references.citation: J Clin Endocrinol Metab. 1991 Oct;73(4):850-6
references.pmid: 1653785
references.citation: J Clin Endocrinol Metab. 1994 Feb;78(2):398-403
references.pmid: 8106629
references.citation: J Endocrinol Invest. 2006 Oct;29(9):826-30
references.pmid: 17114915
references.citation: N Engl J Med. 2005 Jun 9;352(23):2457-8
references.pmid: 15944436
references.citation: Clin Endocrinol (Oxf). 1986 Nov;25(5):561-72
references.pmid: 3621623
references.citation: J Clin Endocrinol Metab. 2008 Apr;93(4):1412-7
references.pmid: 18211974
references.citation: Endocrinology. 1994 Jan;134(1):401-10
references.pmid: 7903933
references.citation: J Clin Endocrinol Metab. 2005 Mar;90(3):1856-63
references.pmid: 15613435
references.citation: Clin Endocrinol (Oxf). 1992 Feb;36(2):171-6
references.pmid: 1348979
references.citation: Endocr Rev. 2006 Aug;27(5):485-534
references.pmid: 16705142
references.citation: J Clin Endocrinol Metab. 1983 Jan;56(1):1-10
references.pmid: 6292253
references.citation: Expert Opin Pharmacother. 2000 Mar;1(3):555-74
references.pmid: 11249538
references.citation: Eur J Endocrinol. 2007 Nov;157(5):579-87
references.pmid: 17984237
references.citation: J Clin Endocrinol Metab. 2001 Nov;86(11):5256-61
references.pmid: 11701688
references.citation: J Endocrinol Invest. 1999 Jan;22(1):64-5
references.pmid: 10090139
references.citation: Clin Endocrinol (Oxf). 2002 Oct;57(4):425-41
references.pmid: 12354124
references.citation: J Endocrinol Invest. 2001 Mar;24(3):183-7
references.pmid: 11314748
references.citation: J Clin Endocrinol Metab. 1997 Nov;82(11):3574-9
references.pmid: 9360509
references.citation: J Clin Endocrinol Metab. 1992 Nov;75(5):1310-7
references.pmid: 1430093
references.citation: J Clin Endocrinol Metab. 2006 Apr;91(4):1397-403
references.pmid: 16449332
references.citation: J Endocrinol Invest. 1999 Apr;22(4):306-9
references.pmid: 10342366
references.citation: J Clin Endocrinol Metab. 1988 Mar;66(3):636-9
references.pmid: 2895119
references.citation: J Clin Endocrinol Metab. 2006 Jun;91(6):2112-8
references.pmid: 16537687
references.citation: J Clin Endocrinol Metab. 1998 Feb;83(2):374-8
references.pmid: 9467544
references.citation: J Endocrinol Invest. 1997 Oct;20(9):537-46
references.pmid: 9413808
references.citation: Clin Endocrinol (Oxf). 1988 Nov;29(5):467-76
references.pmid: 2908102
references.citation: J Clin Endocrinol Metab. 2004 Feb;89(2):638-45
references.pmid: 14764775
references.citation: J Clin Endocrinol Metab. 2000 Apr;85(4):1487-91
references.pmid: 10770186
references.citation: J Clin Endocrinol Metab. 2004 May;89(5):2452-62
references.pmid: 15126577
references.citation: Eur J Endocrinol. 2008 May;158(5):595-603
references.pmid: 18426817
references.citation: Horm Res. 1992;38(1-2):78-83
references.pmid: 1306522
references.citation: Eur J Endocrinol. 2005 Apr;152(4):645-54
references.pmid: 15817922
references.citation: Drugs. 2003;63(22):2473-99
references.pmid: 14609359
references.citation: Ann Intern Med. 1990 May 1;112(9):668-73
references.pmid: 1970714
references.citation: J Clin Endocrinol Metab. 1985 Oct;61(4):666-71
references.pmid: 2863281
references.citation: Eur J Endocrinol. 2002 May;146(5):707-16
references.pmid: 11980628
references.citation: Endocrine. 2003 Apr;20(3):279-83
references.pmid: 12721508
references.citation: J Clin Endocrinol Metab. 1994 Jul;79(1):113-8
references.pmid: 8027215
references.citation: J Clin Endocrinol Metab. 2001 Jun;86(6):2849-53
references.pmid: 11397898
references.citation: J Clin Endocrinol Metab. 2000 Jun;85(6):2247-52
references.pmid: 10852458
references.citation: J Clin Endocrinol Metab. 2001 Nov;86(11):5194-200
references.pmid: 11701676
references.citation: J Endocrinol Invest. 1999 Dec;22(11):860-5
references.pmid: 10710275
references.citation: N Engl J Med. 2003 Nov 20;349(21):2023-33
references.pmid: 14627787
references.citation: Horm Res. 2000;53 Suppl 3:76-87
references.pmid: 10971110
references.citation: Endocr Rev. 1996 Dec;17(6):610-38
references.pmid: 8969971
references.citation: Eur J Endocrinol. 1996 Nov;135(5):548-52
references.pmid: 8980156
references.citation: J Physiol Paris. 2000 May-Aug;94(3-4):205-10
references.pmid: 11087998
references.citation: J Clin Endocrinol Metab. 2005 Jul;90(7):4405-10
references.pmid: 15827109
references.citation: Endocr Rev. 1993 Aug;14(4):443-58
references.pmid: 7693447
references.citation: J Clin Endocrinol Metab. 1998 Jan;83(1):248-52
references.pmid: 9435450
references.citation: J Clin Endocrinol Metab. 2002 Sep;87(9):4054-8
references.pmid: 12213843
references.citation: J Endocrinol Invest. 2006 Dec;29(11):1017-20
references.pmid: 17259801
references.citation: J Endocrinol Invest. 1999 Jan;22(1):40-7
references.pmid: 10090136
references.citation: J Clin Endocrinol Metab. 2008 Aug;93(8):2957-68
references.pmid: 18477663
references.citation: Eur J Endocrinol. 2005 Aug;153(2):187-93
references.pmid: 16061822
references.citation: J Clin Endocrinol Metab. 1997 Feb;82(2):518-23
references.pmid: 9024247
references.citation: Ann Oncol. 2001;12 Suppl 2:S31-6
references.pmid: 11762349
references.citation: N Engl J Med. 1996 Jan 25;334(4):246-54
references.pmid: 8532003
references.citation: Drugs. 1994 Mar;47(3):425-45
references.pmid: 7514973
references.citation: Endocrinol Metab Clin North Am. 2008 Mar;37(1):135-49, ix
references.pmid: 18226734
references.citation: J Endocrinol Invest. 2005;28(11 Suppl International):5-9
references.pmid: 16625838
references.citation: Clin Endocrinol (Oxf). 1997 Nov;47(5):589-98
references.pmid: 9425399
references.citation: J Clin Endocrinol Metab. 1987 Jul;65(1):65-73
references.pmid: 3034958
references.citation: Ann Intern Med. 1993 Aug 1;119(3):236-40
references.pmid: 8323093
references.citation: Eur J Endocrinol. 1998 Nov;139(5):516-21
references.pmid: 9849816
references.citation: Eur J Endocrinol. 2007 Jul;157(1):39-46
references.pmid: 17609400
references.citation: J Clin Endocrinol Metab. 2004 Sep;89(9):4493-502
references.pmid: 15356054
references.citation: J Clin Endocrinol Metab. 2004 Apr;89(4):1674-83
references.pmid: 15070930
references.citation: J Clin Endocrinol Metab. 1996 Aug;81(8):3084-90
references.pmid: 8768879
references.citation: Metabolism. 1996 Aug;45(8 Suppl 1):67-71
references.pmid: 8769387
references.citation: Clin Endocrinol (Oxf). 1994 Mar;40(3):421-8
references.pmid: 8187308
references.citation: Pituitary. 2004;7(2):107-10
references.pmid: 15761660
references.citation: Clin Endocrinol (Oxf). 2007 Aug;67(2):282-9
references.pmid: 17524029
references.citation: Physiol Rev. 1998 Jan;78(1):189-225
references.pmid: 9457173
references.citation: Ann Endocrinol (Paris). 2002 Apr;63(2 Pt 3):2S5-12
references.pmid: 12037501
references.citation: J Clin Endocrinol Metab. 1991 Dec;73(6):1248-55
references.pmid: 1720125
references.citation: Acta Endocrinol (Copenh). 1991 Apr;124(4):487-91
references.pmid: 2031445
references.citation: Neurosurgery. 1997 Oct;41(4):786-95; discussion 796-7
references.pmid: 9316039
references.citation: Endocr Rev. 1992 May;13(2):220-40
references.pmid: 1352243
references.citation: J Endocrinol Invest. 1993 Jul-Aug;16(7):541-3
references.pmid: 8227984
references.citation: J Clin Endocrinol Metab. 1992 Nov;75(5):1318-25
references.pmid: 1358910
references.citation: Mayo Clin Proc. 1997 Oct;72(10):893-900
references.pmid: 9379690
references.citation: J Clin Endocrinol Metab. 2007 Jan;92(1):65-9
references.pmid: 17032724
references.citation: J Clin Endocrinol Metab. 1999 Jul;84(7):2518-22
references.pmid: 10404830
references.citation: Eur J Endocrinol. 2007 Apr;156 Suppl 1:S57-S63
references.pmid: 17413190
references.citation: Clin Endocrinol (Oxf). 2000 Apr;52(4):437-45
references.pmid: 10762286
references.citation: Clin Endocrinol (Oxf). 2001 Jan;54(1):23-30
references.pmid: 11167922
references.citation: J Endocrinol Invest. 1999 Mar;22(3):176-83
references.pmid: 10219884
references.citation: Neurosurgery. 1989 Dec;25(6):948-50
references.pmid: 2532309